Agenus (AGEN) vs Cabaletta Bio (CABA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Agenus (AGEN) has outperformed Cabaletta Bio (CABA) over the past year, gaining 78.1% versus a loss of 15.1%. Over five years, CABA leads with a -83.9% price change compared with -92.7% for AGEN. Agenus is the larger company by market cap ($341.9 million vs $334.0 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AGEN | CABA |
|---|---|---|
| Share price | $7.57 | $1.97 |
| Market cap | $341.88M | $334.00M |
| 1-day change | +1.07% | -2.48% |
| YTD return | +141.08% | -10.05% |
| 1-year return | +78.12% | -15.09% |
| 5-year return | -92.74% | -83.93% |
| P/E ratio (TTM) | 2.99 | — |
| EPS (TTM) | $2.53 | $-1.51 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $10.31 | $4.23 |
| 52-week low | $2.71 | $1.83 |
| Distance from 52-week high | -26.58% | -53.43% |
| Average volume | 4.25M | 4.71M |
| Shares outstanding | 45.16M | 169.55M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- AGEN has outperformed CABA by 93.2 percentage points over the past year.
AGEN vs CABA FAQ
Which is bigger, Agenus or Cabaletta Bio?
Agenus (AGEN) is larger, with a market capitalization of $341.88M compared with $334.00M for Cabaletta Bio (CABA).
Which stock has performed better over the past year, AGEN or CABA?
AGEN returned +78.12% over the past 12 months, compared with -15.09% for CABA (price return, excluding dividends). Past performance does not predict future results.
Are Agenus and Cabaletta Bio in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.